Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)

被引:22
作者
Funk, Markus B. [1 ]
Heiden, Margarethe [2 ]
Volkers, Peter [3 ]
Lohmann, Annette [1 ]
Keller-Stanislawski, Brigitte [1 ]
机构
[1] Paul Ehrlich Inst, Div Safety Med Prod & Med Devices, D-63225 Langen, Germany
[2] Paul Ehrlich Inst, Div Transfus Med, D-63225 Langen, Germany
[3] Paul Ehrlich Inst, Sect Biostat, D-63225 Langen, Germany
关键词
Reporting rate; Risk minimisation measures; Blood components; Transfusion reaction; Haemovigilance; ACUTE LUNG INJURY; REDUCTION; PLASMA;
D O I
10.1159/000381996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To assess the impact of safety measures, we compared reporting rates of transfusion-related reactions before and after the implementation of six measures in 1999, 2004, 2006, 2008 and 2009. Methods: Reporting rates of transfusion-transmitted bacterial infection (TTBI), viral infection (TTVI) and immune-mediated transfusion-related acute lung injury (TRALI) were calculated on the basis of confirmed annual reports and distributed blood components. Results: The introduction of HCV NAT testing caused a significant reduction of HCV reporting rate from 1:0.6 to 1:83.16 million administered blood components (p < 0.0001), donor screening for antibodies to hepatitis B core antigen caused a reduction of HBV reporting rate from 1:2.90 to 1:10.70 million units (p = 0.0168). A significant reduction from 1:0.094 to 1:2.42 million fresh frozen plasma (FFP) units could also be achieved by risk minimisation TRALI measures (p < 0.0001). Implementation of pre-donation sampling did not result in a significant decrease in TTBI, whereas limitation of shelf life for platelet concentrate (PC) minimised the TTBI reporting rate from 1:0.088 to 1:0.19 million PC units (p = 0.041). For HIV NAT pool testing, no significant reduction in HIV transmission was found due to very low reporting rates (1:10 million versus 1:27 million blood components, p = 0.422). Conclusion: On the basis of haemovigilance data, a significant benefit could be demonstrated for four of six implemented safety measures. (C) 2015 S. Karger GmbH, Freiburg
引用
收藏
页码:240 / 246
页数:7
相关论文
共 19 条
[1]  
[Anonymous], 2012, ANN HEMOVIGILANCE RE
[2]   Pathogen-reduced platelets for the prevention of bleeding [J].
Butler, Caroline ;
Doree, Carolyn ;
Estcourt, Lise J. ;
Trivella, Marialena ;
Hopewell, Sally ;
Brunskill, Susan J. ;
Stanworth, Simon ;
Murphy, Michael F. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (03)
[3]   Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma [J].
Chapman, Catherine E. ;
Stainsby, Dorothy ;
Jones, Hilary ;
Love, Elizabeth ;
Massey, Edwin ;
Win, Nay ;
Navarrete, Cristina ;
Lucas, Geoff ;
Soni, Neil ;
Morgan, Cliff ;
Choo, Louise ;
Cohen, Hannah ;
Williamson, Lorna M. .
TRANSFUSION, 2009, 49 (03) :440-452
[4]   Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands [J].
de Korte, D ;
Curvers, J ;
de Kort, WLAM ;
Hoekstra, T ;
van der Poel, CL ;
Beckers, EAM ;
Marcelis, JH .
TRANSFUSION, 2006, 46 (03) :476-485
[5]   Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008) [J].
Eder, Anne F. ;
Herron, Ross M., Jr. ;
Strupp, Annie ;
Dy, Beth ;
White, Jenni ;
Notari, Edward P. ;
Dodd, Roger Y. ;
Benjamin, Richard J. .
TRANSFUSION, 2010, 50 (08) :1732-1742
[6]   Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010) [J].
Funk, Markus B. ;
Lohmann, Annette ;
Guenay, Serife ;
Henseler, Olaf ;
Heiden, Margarethe ;
Hanschmann, Kay-Martin O. ;
Keller-Stanislawski, Brigitte .
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2011, 38 (04) :266-271
[7]   Is Anesthesia Dangerous? [J].
Gottschalk, Andre ;
Van Aken, Hugo ;
Zenz, Michael ;
Standl, Thomas .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (27) :469-474
[8]  
Jutzi M, 2013, FORUM MED SUISSE, V13, P222
[9]   The German Haemovigilance System-reports of serious adverse transfusion reactions between 1997 and 2007 [J].
Keller-Stanislawski, B. ;
Lohmann, A. ;
Guenay, S. ;
Heiden, M. ;
Funk, M. B. .
TRANSFUSION MEDICINE, 2009, 19 (06) :340-349
[10]   Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel [J].
Kleinman, S ;
Caulfield, T ;
Chan, P ;
Davenport, R ;
McFarland, I ;
McPhedran, S ;
Meade, M ;
Morrison, D ;
Pinsent, T ;
Robillard, P ;
Slinger, P .
TRANSFUSION, 2004, 44 (12) :1774-1789